Page last updated: 2024-08-25

sofosbuvir and Inflammation

sofosbuvir has been researched along with Inflammation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Grønbaek, H; Kazankov, K; Kristensen, LH; Laursen, AL; Laursen, TL; Leutscher, P; Møller, HJ; Sandahl, TD; Siggaard, CB; Tarp, B1
Abdel Moneim, A; Mabrouk, D; Mahmoud, B; Suleiman, HA; Zaky, MY1
Fiel, MI; Putra, J; Schiano, TD1
Almeida, JR; Ancuta, P; de Andrade, TG; de Azeredo, EL; do Rosário, NF; Lacerda, GS; Leite, PEC; Medeiros, T; Saraiva, GN; Silva, AA; Xavier, AR1
Abou El-Khier, NT; Abousamra, NK; Arafa, MM; Eladl, E; Elhammady, D; Esmael, ME; Shahin, D; Shaker, G; Sharaf-Eldeen, O1

Trials

1 trial(s) available for sofosbuvir and Inflammation

ArticleYear
Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.
    Clinical and experimental medicine, 2020, Volume: 20, Issue:2

    Topics: Adult; Antiviral Agents; Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Female; Genotype; Glycated Hemoglobin; Hepacivirus; Hepatitis C; Humans; Imidazoles; Inflammation; Insulin Resistance; Interleukin-1beta; Male; Middle Aged; Pyrrolidines; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine

2020

Other Studies

4 other study(ies) available for sofosbuvir and Inflammation

ArticleYear
Time-dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C.
    Journal of viral hepatitis, 2020, Volume: 27, Issue:1

    Topics: Antiviral Agents; Elasticity Imaging Techniques; Female; Hepatitis C, Chronic; Humans; Inflammation; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Sofosbuvir; Sustained Virologic Response; Time Factors; Treatment Outcome

2020
Histological assessment of the liver explant in transplanted hepatitis C virus patients achieving sustained virological response with direct-acting antiviral agents.
    Histopathology, 2018, Volume: 72, Issue:6

    Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Female; Fluorenes; Hepatitis C, Chronic; Humans; Inflammation; Liver Transplantation; Male; Middle Aged; Ribavirin; Simeprevir; Sofosbuvir; Uridine Monophosphate

2018
Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: Chemokine CCL2; Cytokines; Hepatitis C, Chronic; Humans; Inflammation; Inflammation Mediators; Interleukin-10; Interleukin-15; Interleukin-1beta; Interleukin-4; Plasminogen Activator Inhibitor 1; Sofosbuvir

2018
Th17 and IL-17 as Predictors of Hepatic Inflammation in Patients with Chronic Hepatitis C Virus Infection and Treated With Direct Antiviral Therapy.
    The Egyptian journal of immunology, 2018, Volume: 25, Issue:2

    Topics: Antiviral Agents; Case-Control Studies; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Inflammation; Interleukin-17; Ribavirin; Sofosbuvir; Sustained Virologic Response; Th17 Cells; Treatment Outcome

2018